


To provide a portfolio designed to achieve high and rising income by investing globally, primarily in equities in any economic sector whilst participating in long term capital growth.
| Name | % Net Assets |
|---|---|
| Altria | 3.0% |
| Pfizer | 3.0% |
| Royal Dutch Shell | 2.8% |
| Bristol-Myers Squibb | 2.7% |
| McDonalds | 2.6% |
| Coca-Cola | 2.5% |
| Merck & Co | 2.5% |
| Muenchener Rueckversicherungs | 2.5% |
| Unilever | 2.4% |
| Koninklijke | 2.3% |
| Key | % Net Assets |
|---|---|
| 3.0% | |
| 3.0% | |
| 2.8% | |
| 2.7% | |
| 88.5% |
| Date | 09-Sep-2022 |
|---|---|
| NAV | 72.61p |
| Currency | GBP |
| Change | 0.76p |
| % | 1.06% |
| YTD change | 72.61p |
| YTD % | n/a |
| Fund Inception | 07/02/2007 |
|---|---|
| Fund Manager | n/a |
| TER | 1.68 (31-Jan-2013) |
| Minimum Investment | |
|---|---|
| Initial | £1000 |
| Additional | £100 |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | 4.25% |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| No risk data available. | |
You are here: research